4//SEC Filing
Brown William Michael 4
Accession 0000899243-21-004755
CIK 0001326190other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 7:00 PM ET
Size
10.6 KB
Accession
0000899243-21-004755
Insider Transaction Report
Form 4
Brown William Michael
Acting Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2021-02-01+24,664→ 24,664 total→ Common Stock, par value $0.0001 (24,664 underlying) - Award
Common Stock, par value $0.0001
2021-01-31$12.14/sh+937$11,375→ 16,918 total - Award
Stock Options (option to buy)
2021-02-01+90,000→ 90,000 totalExercise: $16.71Exp: 2031-02-01→ Common Stock, par value $0.0001 (90,000 underlying)
Footnotes (5)
- [F1]These shares were purchased due to participation by the reporting individual in the issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from August 1, 2020 through January 31, 2021.
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 31, 2021.
- [F3]Twenty-five percent of the shares underlying the option become vested and exercisable on February 1, 2022 and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date.
- [F4]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
- [F5]The RSUs become vested and exercisable in substantially equal annual installments over the 4 years following February 2, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001742241
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 7:00 PM ET
- Size
- 10.6 KB